Innate immune response to sars‐cov‐2 infection: From cells to soluble mediators

Abstract

The vulnerability of humankind to SARS‐CoV‐2 in the absence of a pre‐existing immunity, the unpredictability of the infection outcome, and the high transmissibility, broad tissue tropism, and ability to exploit and subvert the immune response pose a major challenge and are likely perpetuating the COVID‐19 pandemic. Nevertheless, this peculiar infectious scenario provides researchers with a unique opportunity for studying, with the latest immunological techniques and understandings, the immune response in SARS‐CoV‐2 naïve versus recovered subjects as well as in SARS‐CoV‐2 vaccinees. Interestingly, the current understanding of COVID‐19 indicates that the combined action of innate immune cells, cytokines, and chemokines fine‐tunes the outcome of SARS‐CoV‐2 infection and the related immunopathogenesis. Indeed, the emerging picture clearly shows that the excessive inflammatory response against this virus is among the main causes of disease severity in COVID‐19 patients. In this review, the innate immune response to SARS‐CoV‐2 infection is described not only in light of its capacity to influence the adaptive immune response towards a protective phenotype but also with the intent to point out the multiple strategies exploited by SARS‐CoV‐2 to antagonize host antiviral response and, finally, to outline inborn errors predisposing individuals to COVID‐19 disease severity.